Navigation Links
MU researcher receives $1.5 Million NIH grant to study vascular functions in Alzheimer's
Date:5/21/2014

COLUMBIA, Mo. Alzheimer's is a progressive brain disease that affects older adults, slowly destroys their memories and may cause dementia. According to estimates from the National Institutes of Health (NIH), the disease may affect as many as 5.1 million Americans. Now, with the help of a $1.5 million grant from the NIH, University of Missouri researcher James Lee will continue to look for clues into the causes of Alzheimer's.

"Alzheimer's is an extremely complex disease," said Lee, an associate professor of bioengineering in the MU College of Engineering. "Our research team focuses on a protein, amyloid-beta peptide, which is present at toxic levels in the brains of Alzheimer's patients. We hope to find links between the peptide and the inevitable damage to blood capillaries in the brain."

In the brains of Alzheimer's patients, amyloid-beta peptide (A-beta) adversely interacts with astrocytes, or star-shaped cells that provide structural and metabolic support to neurons and control transmissions in the brain. Astrocytes also provide maintenance to the blood-brain barrier, which protects the brain from harmful neurotoxins and infections.

Lee and his collaborator, Grace Sun, a professor in the Department of Biochemistry at MU, are using biophysical engineering techniques, including atomic force microscopy, which is an instrument that probes and measures cell mechanics with sharp tips. Information is then collected and analyzed to determine how the cells function. Lee's study will focus on how A-beta interacts with cerebral endothelial cells, resulting in the change of cell function.

"When A-beta interacts with blood capillaries in brains affected by Alzheimer's, cell signalings occur that essentially cause capillaries to break down," Lee said. "Until now, this key vascular factor leading to neuronal degeneration in the brain has been understudied. The grant provided by the NIH will help us add novel information about Alzheimer's, and our findings will help inform future research as we look for treatments and cures."


'/>"/>

Contact: Jeff Sossamon
sossamonj@missouri.edu
573-882-3346
University of Missouri-Columbia
Source:Eurekalert  

Related biology news :

1. Illinois researchers combine weak chemical forces to strengthen novel imaging technology
2. NHAES researchers receive $482,500 grant to study nitrogen loss in soils
3. Researchers test whether Red Queen hypothesis makes species resilient
4. NIH researchers discover key factor in early auditory system development
5. Eskitis links with European life science researchers
6. Researchers identify link between colon cancer and metabolism
7. Researchers find a new gene expression mechanism of PRRS virus
8. Researchers find new molecule to treat asthma
9. JAX researchers identify potential therapeutic target for wound-healing and cancer
10. Henry Ford researchers identify genetic factors that may aid survival from brain cancer
11. Oregon researchers capture handoff of tracked object between brain hemispheres
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MU researcher receives $1.5 Million NIH grant to study vascular functions in Alzheimer's
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... analysis of the bioinformatic market by reviewing the ... computer enabled tools that drive the field forward. ... report to: Identify the challenges and opportunities ... service providers and software solution developers, as well ...
(Date:2/1/2016)... , February 1, 2016 ... advancements to drive global touchfree intuitive gesture control market ... --> Rising sales of consumer electronics coupled with ... control market size through 2020 ... electronics coupled with new technological advancements to drive global ...
(Date:1/25/2016)... BLUE BELL, Pa. , Jan. 25, 2016   Unisys ... facial recognition system at John F. Kennedy (JFK) International Airport, ... and Border Protection (CBP) identify imposters attempting to enter ... or do not belong to them. pilot testing ... rolled out initially at three terminals at JFK during January 2016. ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... February 11, 2016 ... or "Company") (OTCQB: PSID), a life sciences company ... its Thermomedics subsidiary, which markets the Caregiver® FDA-cleared ... plan in January 2016, including entering into agreements ... monthly sales growth, and establishing several near-term pipeline ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... York, New York (PRWEB) , ... ... ... Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has joined the Human ... and immunotherapies for infectious diseases and cancer. , The Human Vaccines ...
(Date:2/10/2016)... ... February 10, 2016 , ... HOLLOWAY AMERICA, a ... Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor Exhibition on Thursday, February 18, ... 100 tables for its annual event, which will run from 3:00 p.m. - ...
Breaking Biology Technology: